Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
1/31/2026
Recent Official and Executive Moves
1/31/2026
China's Vaccine Exports Jump More Than 50% in 2025 as Overseas Shipmen...
1/30/2026
China's Basic Medical Insurance Fund Posts Solid Surplus in 2025 as In...
1/30/2026
China Solicits Comments on 103rd Batch of Reference Formulations for C...
1/30/2026
China Releases New Guideline on CMC Changes for Cell Therapy Products
1/30/2026
CDE Issues New Clinical Trial Guideline for Antifibrotic Drugs in Inte...
1/30/2026
CDE Issues Trial Guideline to Standardize Clinical Development of Anti...
1/30/2026
Roche's 2025 Results Highlight Strong China Growth amid Global Expansi...
1/30/2026
CSPC's SYS6055 Becomes First In Vivo CAR-T Therapy Approved for Clinic...
1/30/2026
CMS Secures NMPA Approval for Opzelura in Non-Segmental Vitiligo
1/30/2026
Sciwind Receives China Approval for Ecnoglutide Injection in Type 2 Di...
1/30/2026
SciBrunch Raises Over $35M in Oversubscribed Pre-A Round
1/30/2026
Formation Bio Licenses Oral miR-124 Activator FHND5032 from CTFH for A...
1/30/2026
AstraZeneca Expands Obesity Pipeline Through $18.5B CSPC Collaboration
1/29/2026
Phase III Trial Shows Anbenitamab Significantly Improves Survival in H...
1/29/2026
Sciwind Reports Positive Phase III Results for Ecnoglutide in T2DM
1/29/2026
The United Labs Secures U.S. FDA IND Clearance for Novel β-Lactamase ...
1/29/2026
Novartis Wins Expanded China Approval for Leqvio
1/29/2026
NeuShen Thera Raises US$ Tens of Mlns in Series A+ Financing Led by Li...
1/29/2026
Best-Link Bio Raises Over CNY 200M in Series B to Advance Nanoconjugat...
1/29/2026
AstraZeneca Deepens China Commitment With $15B Investment
1/28/2026
ADB Provides CNY 141M Loan to Support China's Community-Based Pharma ...
1/28/2026
China Issues Trial Guidance on Pharmaceutical Research for Preventive ...
1/28/2026
CDE Issues New Technical Guidance for Clinical Trials of Long-Acting L...
1/28/2026
NMPA Releases 101st Batch of Reference Formulations for Generic Drug E...
1/27/2026
CTTQ's TQA3605 Shows Promising Phase 2 Results in Chronic HBV Treatmen...
1/27/2026
China Warns of Foreign Misuse of Research Ties to Access Biological Sa...
1/27/2026
Lisata Regains Greater China Rights to Pancreatic Cancer Candidate Ahe...
1/27/2026
Insilico Expands AI-Driven Cardiometabolic Pipeline with $120M Qilu Co...
1/27/2026
China Releases 2025 Edition Clinical Guidance on the Use of Novel Anti...
Page:
1
/
60
Total number of articles:
1773
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit